| Literature DB >> 34192011 |
Anne Marte Pensgaard1, Tom Henning Oevreboe1, Andreas Ivarsson2.
Abstract
OBJECTIVE: To investigate the prevalence of mental health problems and satisfaction with life among different groups of elite athletes during a selected period of the COVID-19 pandemic and examine how COVID-19 related consequences were associated with these variables.Entities:
Keywords: COVID-19; anxiety; depression; elite performance; mental
Year: 2021 PMID: 34192011 PMCID: PMC7907612 DOI: 10.1136/bmjsem-2020-001025
Source DB: PubMed Journal: BMJ Open Sport Exerc Med ISSN: 2055-7647
Percentages (95% CI) of Norwegian Olympic and Paralympic athletes and elite and semielite athletes with clinical levels of mental health complaints
| Total population | Females | Males | Δ females versus males | Olympic/para | Elite/semielite | Δ olympic/para versus elite/semielite | |
| Anxiety | 9.3 | 11.3 | 7.8 | 3.5 (−2.2 to 9.4) | 4.6 | 14.1 | −9.5 (−15.3 to −3.7) |
| Depression | 22.5 | 25.8 | 20.1 | 5.7 (−2.7 to 14.1) | 18.0 | 27.2 | −9.2 (−17.5 to −0.7) |
| BIS | 38.6 | 42.8 | 35.6 | 7.2 (−2.7 to 17.1) | 34.5 | 42.9 | −8.4 (−18.2 to 1.4) |
| EDE | 4.5 | 8.8 | 1.4 | 7.4 (3.1 to 11.6) | 4.6 | 4.3 | 0.3 (−3.9 to 4.5) |
| Gambling | 5.6 | 1.3 | 8.7 | −7.4 (−11.9 to −2.7) | 4.1 | 7.1 | −3.0 (−7.6 to 1.2) |
BIS, Bergen Insomnia Scale; EDE, Eating Disorder Examination.
OR (95% CI) for the association between experiences of the COVID-19 situation and mental health for Norwegian Olympic and Paralympic athletes and elite and semielite athletes
| Anxiety | Depression | BIS | EDE | Gambling | |
| Worry infected | 1.15 (0.70 to 1.89) | 1.11 (0.74 to 1.65) | 1.23 (0.87 to 1.75) | 0.86 (0.35 to 2.08) | 0.61 (0.25 to 1.46) |
| Coping | 0.82 (0.54 to 1.26) | 0.81 (0.60 to 1.10) | 0.82 (0.63 to 1.08) | 1.16 (0.54 to 2.48) | 0.64 (0.37 to 1.12) |
| Economy | 1.65 (1.09 to 2.49) | 1.80 (1.33 to 2.45) | 1.11 (0.87 to 1.43) | 0.94 (0.49 to 1.81) | 0.85 (0.50 to 1.46) |
| Restrictions | 1.07 (0.66 to 1.73) | 1.12 (0.80 to 1.57) | 1.23 (0.93 to 1.62) | 1.41 (0.75 to 2.68) | 0.81 (0.44 to 1.49) |
| Death/illness | 1.23 (0.86 to 1.76) | 1.04 (0.79 to 1.35) | 1.11 (0.89 to 1.39) | 0.75 (0.42 to 1.34) | 1.31 (0.81 to 2.13) |
| Routines | 0.71 (0.43 to 1.17) | 0.53 (0.37 to 0.75) | 0.66 (0.48 to 0.89) | 0.58 (0.28 to 1.20) | 0.97 (0.51 to 1.83) |
| Positive consequences | 0.72 (0.43 to 1.20) | 0.93 (0.64 to 1.37) | 0.91 (0.66 to 1.23) | 0.31 (0.15 to 0.67) | 0.52 (0.28 to 0.98) |
| Positive motivation | 1.49 (0.95 to 2.34) | 0.87 (0.65 to 1.17) | 0.92 (0.73 to 1.16) | 1.00 (0.54 to 1.85) | 1.12 (0.70 to 1.80) |
| Negative motivation | 1.22 (0.74 to 2.00) | 1.05 (0.76 to 1.46) | 1.34 (1.02 to 1.73) | 1.12 (0.56 to 2.24) | 0.78 (0.44 to 1.37) |
| Stress | 1.54 (0.97 to 2.45) | 1.24 (0.89 to 1.72) | 0.99 (0.75 to 1.31) | 1.28 (0.68 to 2.42) | 0.90 (0.49 to 1.67) |
| Test | 1.56 (0.53 to 4.53) | 0.69 (0.32 to 1.46) | 1.27 (0.68 to 2.37) | NA | 3.70 (0.45 to 30.30) |
| Gender | 0.89 (0.39 to 2.03) | 0.83 (0.46 to 1.49) | 0.77 (0.48 to 1.26) | 0.14 (0.04 to 0.57) | 8.73 (1.82 to 42.00) |
| Age | 1.01 (0.94 to 1.08) | 0.96 (0.91 to 1.02) | 1.01 (0.97 to 1.04) | 0.84 (0.72 to 0.99) | 1.01 (0.94 to 1.09) |
| Pseudo R2 | 0.26 | 0.28 | 0.18 | 0.41 | 0.18 |
BIS, Bergen Insomnia Scale; EDE, Eating Disorder Examination.